Serine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activity
about
Cytomegalovirus antivirals and development of improved animal modelsProdrugs of phosphonates and phosphates: crossing the membrane barrierComparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeysApproaches to tyrosine-linked peptidomimetic prodrugs of (S)-HPMP-based acyclic nucleoside phosphonates.Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir.Tyrosine-based 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) prodrugs: synthesis, stability, antiviral activity, and in vivo transport studiesSerine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: synthesis and interaction with hPEPT1.Structure of cyclic nucleoside phosphonate ester prodrugs: an inquiry.Transporter-targeted lipid prodrugs of cyclic cidofovir: a potential approach for the treatment of cytomegalovirus retinitis.Evolution of an amino acid based prodrug approach: stay tuned.Puromycin-sensitive aminopeptidase: an antiviral prodrug activating enzymeSynthesis of peptidomimetic conjugates of cyclic nucleoside phosphonates.Synthesis of a phosphoserine mimetic prodrug with potent 14-3-3 protein inhibitory activity.Room temperature alkynylation of H-phosphi(na)tes and secondary phosphine oxides with ethynylbenziodoxolone (EBX) reagents.
P2860
Q27000998-6845E82B-E97C-4ED4-A6D2-7FD7E1B296DDQ27005712-95D6E3DF-63BB-42F9-A224-969C17B58209Q28741437-C9BF14AE-0168-4FAE-9D15-1A9253690C38Q34955580-BD31E80D-1EBB-4A8D-AA57-3162E2891863Q35046606-3836FE7D-0571-45EF-A8B5-C4977B9FB027Q35194089-0383610B-B97D-41DA-9092-C397F315B18BQ35499525-73D8B960-C434-43D4-A583-3C3FFF15750CQ35662164-7B633833-745D-4A9D-B40B-86768F79D97FQ35892584-66370992-24ED-47DE-8BBD-561C15AB3A7CQ37210087-D0FDDBA7-F495-4069-87A6-D348221135E4Q39341058-E838E8FC-6385-4B76-851C-540171E71223Q41909378-D1ED20F5-5A1A-4F23-97CF-F5A40F2406B8Q41973613-D25D7631-532F-4940-88A3-014B0225CA7EQ52778915-69E6044D-64AC-479D-BD5C-0A195C55568B
P2860
Serine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serine peptide phosphoester pr ...... nsport, and antiviral activity
@en
Serine peptide phosphoester pr ...... sport, and antiviral activity.
@nl
type
label
Serine peptide phosphoester pr ...... nsport, and antiviral activity
@en
Serine peptide phosphoester pr ...... sport, and antiviral activity.
@nl
prefLabel
Serine peptide phosphoester pr ...... nsport, and antiviral activity
@en
Serine peptide phosphoester pr ...... sport, and antiviral activity.
@nl
P2093
P2860
P356
P1476
Serine peptide phosphoester pr ...... nsport, and antiviral activity
@en
P2093
Boris A Kashemirov
Charles E McKenna
Jae Seung Kim
John C Drach
John M Hilfinger
Julie M Breitenbach
Katherine Z Borysko
Larryn W Peterson
Paul Kijek
Stefanie Mitchell
P2860
P304
P356
10.1021/MP8000099
P407
P577
2008-05-16T00:00:00Z